Annual Shareholders Equity
$159.33 M
-$64.14 M-28.70%
December 1, 2023
Summary
- As of February 10, 2025, KNTE annual stockholders equity is $159.33 million, with the most recent change of -$64.14 million (-28.70%) on December 1, 2023.
- During the last 3 years, KNTE annual shareholders equity has fallen by -$233.94 million (-59.49%).
Performance
KNTE Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Shareholders Equity
$159.33 M
-$13.09 M-7.59%
December 1, 2023
Summary
- As of February 10, 2025, KNTE quarterly stockholders equity is $159.33 million, with the most recent change of -$13.09 million (-7.59%) on December 1, 2023.
- Over the past year, KNTE quarterly shareholders equity has dropped by -$13.09 million (-7.59%).
Performance
KNTE Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
KNTE Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -28.7% | -7.6% |
| 3 y3 years | -59.5% | -7.6% |
| 5 y5 years | +1993.7% | -7.6% |
KNTE Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -50.1% | at low | -50.1% | at low |
| 5 y | 5-year | -59.5% | -111.0% | -59.5% | -111.0% |
| alltime | all time | -59.5% | -111.0% | -59.5% | -111.0% |
Kinnate Biopharma Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $159.33 M(-28.7%) | $159.33 M(-7.6%) |
| Sep 2023 | - | $172.42 M(-12.8%) |
| Jun 2023 | - | $197.62 M(-11.3%) |
| Mar 2023 | - | $222.76 M(-0.3%) |
| Dec 2022 | $223.47 M(-30.1%) | $223.47 M(-10.0%) |
| Sep 2022 | - | $248.34 M(-9.3%) |
| Jun 2022 | - | $273.73 M(-7.5%) |
| Mar 2022 | - | $295.82 M(-7.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $319.48 M(-18.8%) | $319.48 M(-6.3%) |
| Sep 2021 | - | $341.03 M(-5.6%) |
| Jun 2021 | - | $361.34 M(-4.6%) |
| Mar 2021 | - | $378.57 M(-3.7%) |
| Dec 2020 | $393.27 M(-2349.0%) | $393.27 M(+157.9%) |
| Sep 2020 | - | $152.50 M(-972.1%) |
| Dec 2019 | -$17.49 M(-329.8%) | -$17.49 M |
| Dec 2018 | $7.61 M | - |
FAQ
- What is Kinnate Biopharma annual stockholders equity?
- What is the all time high annual shareholders equity for Kinnate Biopharma?
- What is Kinnate Biopharma annual shareholders equity year-on-year change?
- What is Kinnate Biopharma quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Kinnate Biopharma?
- What is Kinnate Biopharma quarterly shareholders equity year-on-year change?
What is Kinnate Biopharma annual stockholders equity?
The current annual shareholders equity of KNTE is $159.33 M
What is the all time high annual shareholders equity for Kinnate Biopharma?
Kinnate Biopharma all-time high annual stockholders equity is $393.27 M
What is Kinnate Biopharma annual shareholders equity year-on-year change?
Over the past year, KNTE annual stockholders equity has changed by -$64.14 M (-28.70%)
What is Kinnate Biopharma quarterly stockholders equity?
The current quarterly shareholders equity of KNTE is $159.33 M
What is the all time high quarterly shareholders equity for Kinnate Biopharma?
Kinnate Biopharma all-time high quarterly stockholders equity is $393.27 M
What is Kinnate Biopharma quarterly shareholders equity year-on-year change?
Over the past year, KNTE quarterly stockholders equity has changed by -$13.09 M (-7.59%)